Browsing by Author "Parente, F"
Now showing 1 - 10 of 18
Results Per Page
Sort Options
- Ácido úrico e doença cardiovascularPublication . Guimarães, J; Devesa, N; Dias, P; Parente, F; Alexandrino, MB; Moura, JA
- Amiloidose primária: Perspectiva terapêuticaPublication . Parente, F; Vieira, JD; Pimenta, P; Alexandrino, MB; Serra e Silva, P
- Amiloidose primária: Tratamento e prognósticoPublication . Ascensão, M; Figueiredo, H; Nabais, MJ; Pimenta, P; Parente, F; Paiva, A; Feio, J; Alexandrino, MB; Alves-Moura, JJ
- Amiloidoses sistémicas não familiares: Casuística de um serviço de MedicinaPublication . Ascensão, M; Figueiredo, H; Pontes, J; Paiva, A; Pimenta, P; Parente, F; Feio, J; Alexandrino, MB; Serra e Silva, P
- Arterite de Takayasu: discussão de 3 casos clínicosPublication . Reis, R; Costa, S; Parente, F; Alexandrino, MB; Moura, JA
- Avaliação do percurso intra-hospitalar após a alta de um serviço de Medicina InternaPublication . Dias, P; Parente, F; Gaspar, E; Carrola, P; Alexandrino, MB; Alves-Moura, JJ
- Biópsia de gordura abdominal para pesquisa de substância amilóidePublication . Ascensão, M; Figueiredo, H; Parente, F; Matos, R; Alexandrino, MB; Serra e Silva, P
- Biópsia hepática: evolução numa casuística recentePublication . Devesa, N; Guimarães, J; Carrola, P; Reis, R; Dias, P; Parente, F; Lourenço, A; Alexandrino, MB; Alves-Moura, JJ
- Colite isquémica e ergotamina: um caso clínicoPublication . Carrola, P; Devesa, N; Sequeira, C; Parente, F; Alexandrino, MB; Alves-Moura, JJ
- Colite pseudomembranosa : uma casuística de internamentosPublication . Almeida, N; Silva, N; Parente, F; Portela, F; Gouveia, H; Alexandrino, MB; Alves-Moura, JJ; Freitas, DIntroduction: pseudomembranous colitis (PMC) is an infectious disease that generally begins after antibiotic treatment. Objectives: Characterize the patients with PMC in two Services of a Central Hospital. Material and Methods: we considered the patients admitted in a Medicine (MS) and in a Gastroenterology (GES) Service with primary or secondary diagnosis of PMC, between January/1995 and July/2003 and registered the age, gender, clinical presentation, antibiotics (AB) and other risk factors, diagnostic procedures, complications and treatment. Results: we considered 80 patients (43 - GES and 37 - MS); Mean age - 68,6 ± 17,7 years; 52,5% were male; Antibiotic treatment in the previous 3 months - 85%; Mean time of antibiotic treatment - 10,5 ± 6,1 days. Most Commonly Involved Antibiotics: cephalosporins, amoxicillin/clavulanic acid and quinolones. Associated risk factors: renal insufficiency (22,5%); cardiac insufficiency (22,5%); previously dependent patient ( 36,3%). Diagnostic procedures: toxin search-58 patients ( in 36 ), colonoscopy - 62 ( in 53); culture - 23 (in 17 ). The mortality rate was 18,8% (n = 15); recurrence rate - 10% (n = 8). Therapeutics: metronidazol - 37 patients (46,3%); vancomycin - 24 (30%); metronidazol + vancomycin – 12 (15%). Differences Between Services: mean age (MS - 72,9 and GES - 64,9); admission criteria (GES - intestinal disorders, MS – respiratory infections); diagnostic procedures (colonoscopy more frequent in GES); therapeutic options (MS - metronidazol; GES - vancomycin and metronidazol + vancomycin). Conclusions: PMC is more common in older patients that were generally submitted to previous antibiotic treatment, especially with ß-lactamics. Considering two distinct Services we observed differences concerning age, co-morbility and risk factors that implied distinct diagnostic and therapeutic approaches.